Businesses Can Order Pixel by Labcorp® COVID-19
PCR Test Home Collection Kits Online or Through Labcorp Employer
Services
Labcorp (NYSE: LH), a leading global life sciences company,
today announced the availability of the Pixel by Labcorp® COVID-19
PCR Test Home Collection Kit for small businesses, an initiative
aimed at providing fast, convenient, and reliable testing for
companies with as many as 120 employees. Labcorp Employer Services
currently provides COVID-19 testing and vaccination services for
larger organizations and communities.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210420006151/en/
Photo courtesy of Labcorp
The small business offering enables bulk purchasing, and is
well-suited for restaurants, professional services offices, event
planners and small venue owners. Bulk purchasing saves on shipping
costs, and those savings are passed on to the small business. Kits
can be purchased in multiples of six, with a maximum of 120 kits
per order, at Pixel by Labcorp. Purchases are made with a credit
card.
“By making it easier for employees to get tested, we are
supporting communities and small businesses across the country,”
said Brian Caveney, M.D., chief medical officer and president,
Labcorp Diagnostics. “Pixel by Labcorp offers reliable, trusted,
and convenient COVID-19 testing along with the information needed
for small business owners to make confident decisions in the
interests of their customers and employees. We’re thrilled to work
with small businesses to provide easy access to the same
high-quality PCR tests used by doctors and hospitals as we work to
improve health and improve lives.”
The offering for small businesses is yet another example of the
company’s commitment to expanding access to testing so people can
safely return to work and everyday activities. As states continue
to reopen, small businesses will need a convenient way to ensure
the safety of their employees and patrons. Many of these businesses
are not able to offer remote working environments for their
employees. The small business offering through Pixel by Labcorp
makes it easier than ever for restaurants, production companies,
retailers, and other small businesses to safely operate in their
local communities.
Upon receiving a Pixel by Labcorp COVID-19 PCR Test Home
Collection Kit from their employer or an event organizer,
individuals self-administer the test using a short nasal swab and
send their sample back to Labcorp via prepaid FedEx Express
overnight. Results are typically available within 1-2 days from
when Labcorp receives the sample. Once the test is processed by
Labcorp, results are accessed securely by the employee via the
Pixel by Labcorp website.
If a COVID-19 test is positive, a Labcorp-verified healthcare
staff member will contact the individual directly by phone or mail
to discuss next steps. Pixel by Labcorp has contracted with a
physician network to provide independent physician services for
consultation.
Labcorp’s COVID-19 PCR test has not been FDA cleared or approved
and has been authorized by the FDA under an emergency use
authorization only for the detection of nucleic acid from
SARS-CoV-2, not for any other viruses or pathogens. The test is
only authorized for the duration of the declaration that
circumstances exist justifying the authorization of emergency use
of in vitro diagnostic tests for detection and/or diagnosis of
COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. §
360bbb-3(b)(1), unless the authorization is terminated or revoked
sooner.
About Labcorp
Labcorp is a leading global life sciences company that provides
vital information to help doctors, hospitals, pharmaceutical
companies, researchers, and patients make clear and confident
decisions. Through our unparalleled diagnostics and drug
development capabilities, we provide insights and accelerate
innovations to improve health and improve lives. With over 70,000
employees, we serve clients in more than 100 countries. Labcorp
(NYSE: LH) reported revenue of $14 billion in FY2020. Learn about
Labcorp at www.Labcorp.com, or follow us on LinkedIn and Twitter
@Labcorp.
Cautionary Statement Regarding Forward-Looking
Statements
This press release contains forward-looking statements,
including but not limited to statements with respect to clinical
laboratory testing and the potential benefits of a COVID-19 test
home collection kit and our responses to and the expected future
impacts of the COVID-19 pandemic and the opportunities for future
growth.
Each of the forward-looking statements is subject to change
based on various important factors, many of which are beyond the
company’s control, including without limitation, the impact of the
COVID-19 pandemic and its impact on our business and financial
condition and on general economic, business, and market conditions,
our ability (or inability) to execute on our plans to respond to
the COVID-19 pandemic, competitive actions and other unforeseen
changes and general uncertainties in the marketplace, changes in
government regulations, including healthcare reform, customer
purchasing decisions, including changes in payer regulations or
policies, other adverse actions of governmental and third-party
payers, changes in testing guidelines or recommendations, federal,
state, and local government responses to the COVID-19 pandemic, the
effect of public opinion on the company’s reputation, adverse
results in material litigation matters, the impact of changes in
tax laws and regulations, failure to maintain or develop customer
relationships, our ability to develop or acquire new products and
adapt to technological changes, failure in information technology,
systems or data security, adverse weather conditions, the number of
revenue days in a financial period, employee relations, personnel
costs, and the effect of exchange rate fluctuations. These factors,
in some cases, have affected and in the future (together with other
factors) could affect the company’s ability to implement the
company’s business strategy and actual results could differ
materially from those suggested by these forward-looking
statements. As a result, readers are cautioned not to place undue
reliance on any of our forward-looking statements.
The company has no obligation to provide any updates to these
forward-looking statements even if its expectations change. All
forward-looking statements are expressly qualified in their
entirety by this cautionary statement. Further information on
potential factors, risks and uncertainties that could affect
operating and financial results is included in the company’s most
recent Annual Report on Form 10-K and subsequent Forms 10-Q,
including in each case under the heading RISK FACTORS, and in the
company’s other filings with the SEC. The information in this press
release should be read in conjunction with a review of the
company’s filings with the SEC including the information in the
company’s most recent Annual Report on Form 10-K, and subsequent
Forms 10-Q, under the heading MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
# # #
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210420006151/en/
Labcorp Contacts: Media: Christopher Allman-Bradshaw —
336-436-8263 Media@Labcorp.com
Investors: Chas Cook —
336-436-5076 Investor@Labcorp.com
Labcorp (NYSE:LH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Labcorp (NYSE:LH)
Historical Stock Chart
From Sep 2023 to Sep 2024